NCT04403477View on ClinicalTrials.gov

Convalescent Plasma Therapy in Severe COVID-19 Infection

PHASE2UnknownINTERVENTIONAL

Enrollment

20

Participants

Timeline

Start Date

May 20, 2020

Primary Completion Date

July 20, 2020

Study Completion Date

October 30, 2020

Conditions

Covid19Convalescence

Interventions

BIOLOGICAL

Convalescent plasma

Apheretic convalescent plasma from a COVID-19 survivor

Trial Locations (1)

1200

RECRUITING

Bangabandhu Sheikh Mujib Medical University, Dhaka

Sponsors

Collaborators (1)

Dhaka Medical College

All Listed Sponsors

collaborator

Dhaka Medical College

OTHER

lead

Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh

OTHER

NCT04403477 - Convalescent Plasma Therapy in Severe COVID-19 Infection | Biotech Hunter | Biotech Hunter